(PharmaNewsWire.Com, October 05, 2017 ) The medical electrodes market is expected to reach USD 732.4 Million by 2022 from USD 583.2 Million in 2017, at a CAGR of 4.7%. A number of factors such as rising incidence and prevalence of neurological and cardiovascular disorders, increasing investments in medical device research, and growing preference for home and ambulatory healthcare are driving the growth of this market. In addition, emerging markets such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the market. <||>rnhttp://www.marketsandmarkets.com/Market-Reports/medical-electrode-market-171260948.html
This report segments the medical electrodes market is segmented based on usability, technology, diagnostic procedure, application, and region. Based on usability, the market is segmented into disposable and reusable electrodes. The disposable electrodes segment is expected to account for the largest market share in 2016. On the basis of technology, the market is further divided into wet electrodes, dry electrodes, and needle electrodes. The dry electrodes segment is expected to register the highest CAGR during the forecast period. Dry electrodes offer higher patient comfort, and this segment is witnessing numerous technological advancements focused towards developing products that provide high signal quality and better patient comfort. These factors are driving its growth in the market.
Based on the diagnostic procedures the market is segmented into electrocardiography (ECG), electroencephalography (EEG), electromyography (EMG), and other procedures [electroretinography (ERG) and electrooculography (EOG)]. Electrocardiography dominated the market in 2016 and to grow at highest CAGR during the forecast period. The rising prevalence of CVD, increasing incidence of arrhythmias, and technological advancements in ECG electrodes are the major factors supporting the growth of the diagnostic medical electrodes market for ECG.
On the basis of application, the market is further segmented into cardiology, neurophysiology, sleep disorders, intraoperative monitoring, and other applications. The cardiology segment is expected to witness the highest growth in the forecast period. The large share of this segment can primarily be attributed to factors such as the increasing prevalence of cardiovascular diseases (CVD), growing geriatric population, rising cardiovascular health awareness, and technological innovations in diagnostics tools and monitoring techniques.
In 2017, North America is expected to dominate the market. Factors such as growing focus on innovative technologies, rising geriatric population, and increasing awareness about the benefits of early disease diagnosis and high healthcare expenditure in the US and Canada are the major factors supporting the growth of this market.
Prominent players in the market include 3M Company (US), Medtronic (Ireland), Ambu (US), Natus Medical Incorporated (US), Rhythmlink International, LLC (US), Koninklijke Philips N.V. (Netherlands), Cognionics, Inc. (US), CONMED Corporation (US), Leonhard Lang GmbH (acquired by DCC plc), and Nihon Kohden Corporation (Japan).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
